Ada Chen
Rutgers, The State University of New Jersey(US)Kessler Foundation(US)Rutgers New Jersey Medical School
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Adenosine and Purinergic Signaling, Nanoparticle-Based Drug Delivery, Peptidase Inhibition and Analysis, Synthesis and Biological Evaluation
Most-Cited Works
- → The adoption of virtual banking: an empirical study(1999)429 cited
- Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression.(1999)
- → Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development(2014)291 cited
- → Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction(2012)167 cited
- → The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents(2015)145 cited
- → Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression(2001)90 cited
- → Discovery of AB680: A Potent and Selective Inhibitor of CD73(2020)87 cited